Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation

International Journal of Hematology

Volumn 82, Issue 5, 2005, Pages 449-455

  Takami, Akiyoshi ^a   Okumura, Hirokazu ^a   Yamazaki, Hirohito ^a   Kami, Masahiro ^b   Kim, Song Wong ^b   Asakura, Hidesaku ^a   Endo, Tomoyuki ^c   Nishio, Mitsuyuki ^c   Minauchi, Koichiro ^c   Kumano, Koki ^c   Sugimori, Naomi ^a   Mori, Shinichiro ^b   Takemoto, Yoshitada ^d   Shimadoi, Shigeru ^a   Ozaki, Jun ^a   Takaue, Yoichi ^b   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d IMAMURA BUN IN HOSPITAL   (Japan)

Author keywords

Acute leukemia relapse; Graft versus leukemia effect; High dose ara C; Megadose donor lymphocyte infusion; Peripheral blood stem cells

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; TACROLIMUS; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; LYMPHOCYTE; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL; SEPSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ALLOTRANSPLANTATION; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; LEUKEMIA; LYMPHOCYTE TRANSFUSION; METHODOLOGY; MIDDLE AGED; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDY; RECURRENT DISEASE; REMISSION;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33646449373     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05086     Document Type: Article

References (31)

1. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 2004;103: 767-776.
2. Shiobara S, Nakao S, Ueda M, et al. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplant. 2000;26: 769-774.
3. Fassas AB, Rapoport AP, Cottler-Fox M, Chen T, Tricot G. Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation. Br J Haematol. 2000;111:662-667.
4. Sullivan KM, Deeg HJ, Sanders J, et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood. 1986;67:1172-1175.
5. Verfaillie CM, Weisdorf D, McGlave PB, et al. High dose donor mononuclear cell infusion in posttransplant relapsed AML/MDS. Blood. 1994;84:333a.
6. Speck B, Bortin MM, Champlin R, et al. Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet. 1984; 1:665-668.
7. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med. 1975;292:895-902.
8. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
9. Nakao S, Nakatsumi T, Chuhjo T, et al. Analysis of late graft failure after allogeneic bone marrow transplantation: detection of residual host cells using amplification of variable number of tandem repeats loci. Bone Marrow Transplant. 1992;9:107-111.
10. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86: 2041-2050.
11. Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433-444.
12. Collins RH Jr, Goldstein S, Giralt S, et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant. 2000;26:511-516.
13. Munker R, Schmid C, Madrigal JA, Kolb HJ. An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the Sixth International Symposium held in Schloss Ellmau, Germany. January 22-24, 2004. Bone Marrow Transplant. 2004;34:767-780.
14. Levine JE, Braun T, Penza SL, et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol. 2002;20:405-412.
15. Schmid C, Alessandrino E, Bunjes D, et al. Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with donor lymphocyte transfusion: a retrospective analysis of EBMT results. Blood. 2000;96:477a.
16. Kim JG, Sohn SK, Kim DH, et al. A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant. 2004;33: 231-236.
17. Glass B, Majolino I, Dreger P, et al. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant. 1997;20:533-541.
18. Drobyski WR, Baxter-Lowe LA, Truitt RL. Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease. Blood. 1993;81:551-559.
19. Slavin S, Or R, Kapelushnik Y, et al. Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT). Leukemia. 1992;6(suppl 4): 164-166.
20. Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydlo R, Zwaan FE. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission: a report by the EBMT Leukaemia Working Party. Br J Haematol. 1991;79: 567-574.
21. Mrsic M, Horowitz MM, Atkinson K, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant. 1992;9:269-275.
22. Kishi K, Takahashi S, Gondo H, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant. 1997;19:461-466.
23. Bosi A, Bacci S, Miniero R, et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia. 1997;11:420-424.
24. Mehta J, Powles R, Treleaven J, et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant. 1997;19:709-719.
25. Michallet M, Tanguy ML, Socie G, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol. 2000;108:400-407.
26. Bosi A, Laszlo D, Labopin M, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood, and Marrow Transplantation. J Clin Oncol. 2001;19:3675-3684.
27. Wagner JE, Vogelsang GB, Zehnbauer BA, Griffin CA, Shah N, Santos GW. Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy. Bone Marrow Transplant. 1992;9:205-209.
28. Frassoni F, Barrett AJ, Granena A, et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol. 1988;70:317-320.
29. Tringali S, Vasta S, Scime R, Catania P, Cavallaro AM, Majolino I. Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion. Haematologica. 1996;81: 339-342.
30. Endo T, Sato N, Koizumi K, et al. Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. Am J Hematol. 2004;76:279-282.
31. Tamaki H, Mishima M, Kawakami M, et al. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). Int J Hematol. 2003;78:349-356.